Diploma in Pharmacist recognized by the Government of Chhattisgarh. Registration of the pharmacy as a pharmacist.

B.Pharm / M.Pharm should be registered with Gujarat Pharmacy Council.

Master degree in Natural Science Biological Sciences, Physical Sciences or in Pharmacy from a recognized University or equivalent with minimum of 55% marks or equivalent grade.

Approved Diploma m Pharmacy, B.Pharmacy from a recognized institute. ECHS invites applications to engage following Officer Staff, Para Medical Staff and Non Medical Staff.

Masters, Integrated Masters in Natural or Agricultural or Pharmaceutical Sciences OR Bachelors Degree in Engineering or Technology or Medicine from a recognized University

M.Pharm, M.Pharm Ayurveda, M.S. Pharmaceutical Science From a recognized University and Institution. Preference will be given to those who possess higher qualifications or who have previous research experience on AYUSH & H drugs preparation and their standardization.

Biotechnology, Healthcare including Functional Genomics, Drug Development and Biomedical Devices, Agriculture and Food Sciences

Applicants must be active researchers at any stage in their career with at least one year of graduate research experience or equivalent at the time of application.

Candidates must possess a Master’s degree in Life Sciences, Biochemistry, Biotechnology, Zoology, Bioinformatics, or allied areas with at least 55% marks from a recognized university.

First Class Post Graduate Degree, including the integrated PG degrees in Biological Sciences, or Second-Class Post Graduate Degree, including the integrated PG degrees with Ph.D. in Biological Sciences. 

M.Sc. in Botany, Biotechnology, Life Sciences. Biotechnological Intervention with Biological Resources of North Eastern India for Socio-economic Development.

Post Graduate Degree in Life Science OR Graduate / Post Graduate Degree in associated fields. The ideal candidate should have experience in Cell culture and Imaging. Knowledge of NGS data analysis is an added advantage, but it is not a prerequisite.

Post-graduate degree in Life Sciences, Biotechnology, Bioinformatics or equivalent with minimum 60% marks. Identification of lead molecules for development of novel therapeutic strategies against viruses.

M.Sc. in Biotechnology, Botany, Biochemistry from a recognized University or equivalent with two years post M.Sc research experience.

Graduation in the Biotechnology or Microbiology discipline with a good academic track record. OR a postgraduate degree in Biotechnology / Microbiology shall also be considered

M.Sc. in Life Sciences or related disciplines with a minimum of 55% marks or equivalent CGPA. Qualified in NET and or GATE.

Exposure of analysis for Finished Products. Stability Samples and Raw Materials. Having Knowledge of Analytical Method Validation. Verification and Method Transfer. Having skill for data interpretation, troubleshooting.

Pfizer unveiled very encouraging topline results from its Phase 3 BASIS clinical trial (NCT03938792). The study examined once‑weekly, under‑skin injections of HYMPAVZI (marstacimab) in adolescents and adults (12 years+) living with hemophilia A or B complicated by inhibitors an antibody that can neutralize traditional factor replacement therapy.

Vertex Pharmaceuticals has announced that the European Commission has approved its newest cystic fibrosis treatment, ALYFTREK a once-daily, triple-combination therapy made up of deutivacaftor, tezacaftor, and vanzacaftor.